Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.4100
+0.0092 (2.30%)
Mar 3, 2026, 4:00 PM EST - Market closed
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $42.89 million as of March 3, 2026. Its market cap has increased by 79.26% in one year.
Market Cap
42.89M
Enterprise Value
65.76M
1-Year Change
79.26%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $42.89M, an increase of 24.36%. That is a compound annual growth rate of 16.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 42.89M | -18.81% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OS Therapies | 51.77M |
| MiNK Therapeutics | 51.40M |
| Estrella Immunopharma | 51.28M |
| Kezar Life Sciences | 49.07M |
| Acrivon Therapeutics | 47.65M |
| NextCure | 44.59M |
| Telomir Pharmaceuticals | 43.66M |
| Apollomics | 43.37M |